Real-World Treatment Patterns and Outcomes in HER2-Altered Metastatic Breast Cancer Patients in the United States
Clinical trial NCT07342309 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07342309
- Sponsor
- Boehringer Ingelheim
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2025-09-30
- Primary completion
- 2026-10-30
- Enrollment
- 7933
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.